Gabriel T. Scott

Advised a leading Tennessee-based health system on health care regulatory matters, including the preparation and submission of several hundred licensure filings in connection with its US$1.34 billion acquisition of a long-term acute care, rehabilitation services, and behavioral health services provider and the related launch of a new, national health system combining acute and post-acute hospitals from both parties.

Counseled an artificial intelligence-based precision medicine company on health care regulatory compliance matters related to federal and state physician supervision rules and Medicare enrollment requirements for independent diagnostic testing facilities.

Assessed health care regulatory matters, including issues related to reimbursement, licensure, and Medicare billing compliance, for a national durable medical equipment (“DME”) supplier in its strategic acquisitions of national and regional DME and other health care companies.

Represented a health system in a complex licensure matter before the California State Board of Pharmacy related to changes of ownership at more than a dozen long-term care hospitals.

Counsel for a health system in a licensure matter before the Nevada State Board of Pharmacy.

Provided health care regulatory advice, including detailed guidance on privacy rules, controlled substances prescriptions, and professional licensure requirements, to a publicly traded company in order to facilitate implementation of a nationwide direct-to-consumer telemedicine platform.

Represented an investor-backed vision group on change-of-ownership matters and other health care compliance issues related to the acquisition of ambulatory surgical centers in Maryland.

Provided health care regulatory analysis of state licensure and privacy rules for a national retailer seeking to establish a retail program for the sale of prescription eyeglasses and contact lenses.

Represented a personal care services provider in South Carolina in its plan of correction response to a compliance survey by the state's Medicaid program.

Represented a California multi-specialty medical group in its plan of correction response to a CMS notice of noncompliance and proposed sanctions.

Prepared technical analysis for a North Carolina hospital of Medicare overpayments liability related to sleep center claims.

Advised a Virginia health system on structuring contractual arrangements with heart monitor suppliers to comply with federal and state health care regulations, including the anti-markup rule and anti-kickback laws.

Analyzed Stark Law compliance of financial relationships with physicians and prepared self-referral disclosures to the CMS Self-Referral Disclosure Protocol for health care provider clients in California, North Carolina, and Tennessee.

Prepared 50-state surveys related to health care licensure matters for a manufacturer and distributer of medical devices in preparation for several acquisitions, including a remote cardiac monitoring service provider and a Medicare-enrolled independent diagnostic testing facility.

Represented a molecular diagnostics company in its acquisition of a CLIA-certified and CAP-accredited sequencing laboratory based in Arizona; provided health care regulatory advice regarding government and private payer issues, including compliance assessment target's use of patient assistance programs and co-pay waivers.

Regulatory counsel to a private hospital for a transaction involving a member substitution between the hospital and a public health department whereby the private hospital became the sole member of the public health department.

Advised a California-based private equity firm on health care regulatory matters related to its leveraged acquisition of a provider of veteran disability benefits services.

Analyzed a physician-owned laboratory’s arrangements for Stark and AKS concerns, and directed revisions to laboratory contracts and operations to resolve noncompliance.

Advised a health system on the creation of a prescription assistance program that complies with federal regulations and OIG guidance.

Drafted internal policies and procedures for a specialty pharmacy standardizing the provision of meals and gifts by salespersons to their physician customers.

Drafted due diligence report and advised a medical device company on compliance with AKS and Physician Sunshine Act reporting requirements as it prepared for an IPO.

Analyzed all the lease arrangements of a large health system and advised on Stark and AKS matters, as well as strategic guidance on self-disclosures, operational considerations, and recommended changes to policies and procedures to promote improved compliance.

As buyer's counsel, performed regulatory due diligence related to hospital change of ownership and processed transfers of licenses, permits, and enrollments.